Your browser doesn't support javascript.
loading
Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors.
Cheng, Yue; Anthony, Lowell; Delcher, Chris; Moga, Daniela C; Chauhan, Aman; Huang, Bin; Adams, Val.
Afiliação
  • Cheng Y; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
  • Anthony L; Institute of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
  • Delcher C; Department of Internal Medicine, Division of Medical Oncology, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Moga DC; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
  • Chauhan A; Institute of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
  • Huang B; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
  • Adams V; Institute of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
Oncologist ; 28(6): 479-485, 2023 06 02.
Article em En | MEDLINE | ID: mdl-36994847
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Síndrome do Carcinoide Maligno Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Síndrome do Carcinoide Maligno Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article